Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease

The Journal of Dermatological Treatment
Megan HohenbergerSteven R Feldman

Abstract

Interleukin 17 (IL-17) antagonism provides a highly effective approach for treating psoriasis. Exacerbations of inflammatory bowel disease have been reported in anti-IL-17 psoriasis trials. To characterize the relationship between IL-17 inhibition and inflammatory bowel disease. A review of English-language articles was performed. Search terms included IL-17, psoriasis, inflammatory bowel disease, secukinumab, ixekizumab and brodalumab. IL-17 A inhibition, IL-17RA inhibition and IL-17 knockout led to induction or exacerbation of colitis in mouse models. The placebo groups fared better than the treatment group in controlled trials of anti-IL-17 antibody and anti-IL-17 receptor for Crohn's disease (CD). A brodalumab study (N = 1576) revealed one reported CD case. An ixekizumab study (N = 3736) evaluating moderate-to-severe psoriasis, four patients reported CD and seven reported UC while ixekizumab every 2 weeks led to a moderate exacerbation of UC in one patient and new-onset CD in one patient. A secukinumab study (N = 3430) revealed exposure adjusted incidence rates of 0.11 and 0.15 per 100 patient-years for CD and UC, respectively. Anti-IL-17 medications are associated with IBD exacerbation. Caution should be used in prescribin...Continue Reading

References

Nov 1, 1991·Annals of Neurology·K SelmajA H Cross
Aug 15, 1991·The New England Journal of Medicine·M K Sharief, R Hentges
Feb 14, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Atsuhiro OgawaYoshihide Fujiyama
Sep 20, 2006·The Journal of Experimental Medicine·Spencer C LiangLynette A Fouser
Oct 6, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jan LinRam Raj Singh
Nov 21, 2007·Clinics in Dermatology·Enno Christophers
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Apr 16, 2008·The Journal of Experimental Medicine·Xuexian O YangChen Dong
Aug 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jill F WrightBeatriz M Carreno
Sep 18, 2008·Biochemical and Biophysical Research Communications·Reiko ItoOsam Mazda
Feb 12, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·A D CohenS Birkenfeld
Mar 20, 2009·The Journal of Investigative Dermatology·Erin G HarperAndrew Blauvelt
May 19, 2009·Nature Immunology·William O'ConnorRichard A Flavell
Jan 1, 2009·Digestive Diseases·Daniel PoulainJean-Frederic Colombel
Feb 26, 2011·Immunity·Yoichiro IwakuraSusumu Nakae
Mar 30, 2012·The New England Journal of Medicine·Kim A PappScott Baumgartner
Oct 2, 2012·Nature Reviews. Drug Discovery·Pierre Miossec, Jay K Kolls
Oct 19, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN CERTIFI Study Group
Dec 13, 2012·Gut·Jean Frédéric ColombelDaniel Poulain
Jun 25, 2013·Autoimmunity Reviews·Shomron Ben-HorinYehuda Chowers
Oct 26, 2013·Seminars in Arthritis and Rheumatism·Wim B van den Berg, Iain B McInnes
Jul 10, 2014·The New England Journal of Medicine·Richard G LangleyUNKNOWN FIXTURE Study Group
Sep 23, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·C PaulUNKNOWN JUNCTURE study group
Oct 1, 2015·The New England Journal of Medicine·Mark LebwohlAjay Nirula
Dec 10, 2015·American Journal of Clinical Dermatology·Theresa N CanavanBoni E Elewski
Jun 15, 2016·The New England Journal of Medicine·Kenneth B GordonUNKNOWN UNCOVER-3 Study Group
Nov 4, 2016·The American Journal of Gastroenterology·Stephan R TarganPaul Klekotka

❮ Previous
Next ❯

Citations

Nov 7, 2017·The Journal of Dermatological Treatment·Daniel J NoJashin J Wu
Oct 24, 2017·The Journal of Dermatological Treatment·Mina AminJashin J Wu
Nov 20, 2018·Expert Review of Clinical Pharmacology·Katherine M StiffSteven R Feldman
Mar 12, 2019·Journal of Cutaneous Medicine and Surgery·Christine FahimSimone Fahim
May 3, 2019·Expert Opinion on Drug Safety·Sree S KolliSteven R Feldman
Oct 12, 2019·Expert Review of Clinical Immunology·Karen LyTina Bhutani
Dec 25, 2019·Expert Opinion on Drug Safety·Lluís Puig
Sep 4, 2019·Expert Opinion on Drug Safety·S D'AdamioM Galluzzo
Feb 14, 2020·Expert Opinion on Drug Safety·Helena Iznardo, Lluís Puig
Apr 10, 2020·Modern Rheumatology·Kentaro NodaAyako Nakajima
Aug 14, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·M NogueiraT Torres
Aug 11, 2020·Journal of Pediatric Gastroenterology and Nutrition·Sara Salvador-MartínLuis A López-Fernández
May 28, 2019·Frontiers in Immunology·Alessandro PoggiMaria Raffaella Zocchi
Jul 17, 2019·Alimentary Pharmacology & Therapeutics·Akihiro YamadaAtsushi Sakuraba
Jul 23, 2020·Therapeutic Advances in Musculoskeletal Disease·Caroline Di Jiang, Tim Raine
Oct 29, 2017·American Journal of Clinical Dermatology·Mina AminJashin J Wu
Nov 6, 2018·Expert Review of Clinical Immunology·Rodney Sinclair, Vetrichevvel Thirthar Palanivelu
Dec 1, 2018·Expert Opinion on Biological Therapy·Annika Silfvast-KaiserAlan Menter
Aug 29, 2019·Expert Review of Clinical Pharmacology·Chuanlan Gu, Junyi Yang
Dec 20, 2019·Clinical and Experimental Dermatology·A S W LeeM A W Tremelling
Feb 19, 2019·The Tohoku Journal of Experimental Medicine·Yuanjun Li, Yedi Zhou
Aug 31, 2019·Case Reports in Medicine·Ted George AchufusiSekou Rawlins
Aug 14, 2019·Frontiers in Immunology·Michael P Schön
Nov 7, 2019·Therapeutic Advances in Musculoskeletal Disease·Giovanni AdamiPiet Geusens
Nov 30, 2019·Mediators of Inflammation·Fang LiuLixin Zhu
Jul 30, 2020·Scientific Reports·Paulina Krawiec, Elżbieta Pac-Kożuchowska
Jun 5, 2020·ERJ Open Research·Gareth M Hynes, Timothy S C Hinks
May 24, 2020·The British Journal of Dermatology·S AfachL Le Cleach
Aug 16, 2018·Clinical Reviews in Allergy & Immunology·Andrew Blauvelt, Andrea Chiricozzi
Jun 18, 2020·World Journal of Clinical Cases·Ze-Yu WuBing Chang
Aug 28, 2020·Gut·Thomas GreuterStephan R Vavricka
Jul 29, 2020·Annals of the Rheumatic Diseases·Marine FaunyLaurent Peyrin-Biroulet
Sep 4, 2020·Immunology·Jemima HoJulian R Naglik
Jan 8, 2021·Clinical Pharmacology and Therapeutics·Nadine PetitpainPierre Gillet
Oct 20, 2020·The Journal of Dermatological Treatment·Claudio ConfortiNicoleta Neagu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.